ProShares Ultra Nasdaq Biotechnology (BIB) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free BIB Stock Alerts $54.47 -0.95 (-1.71%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Down 56.3% in Aprilmarketbeat.com - May 11 at 10:23 AMProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Pass Above 50 Day Moving Average of $54.33americanbankingnews.com - May 11 at 5:29 AMProShares Ultra Bloomberg Natural Gas: Trading Short-Term Tailwinds (Rating Upgrade)seekingalpha.com - April 29 at 5:28 AMProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Significant Growth in Short Interestmarketbeat.com - April 25 at 9:15 PMShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Declines By 77.9%marketbeat.com - April 10 at 10:44 AMProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Up 98.2% in Marchmarketbeat.com - March 28 at 4:32 PMWall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy Richinvestorplace.com - March 25 at 3:00 PMProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.0403msn.com - March 22 at 4:27 PMProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Plans Dividend of $0.04marketbeat.com - March 20 at 6:25 PMShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Rises By 53.6%marketbeat.com - March 14 at 10:42 AMProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above 50 Day Moving Average of $58.27marketbeat.com - March 8 at 5:17 AMProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above Fifty Day Moving Average of $57.97marketbeat.com - February 29 at 6:03 AM3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024investorplace.com - February 22 at 6:00 PMProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Cross Below 50 Day Moving Average of $57.16marketbeat.com - February 21 at 5:58 AMProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.0383msn.com - December 20 at 12:48 PM5 Most Promising Biotech Stocks to Buy According to Analystsinsidermonkey.com - December 15 at 12:29 PMBIB ETF Stock Price Historyinvesting.com - October 29 at 5:41 PMProShares Trust - ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB)fool.com - June 18 at 12:24 AMBIB - ProShares Ultra Nasdaq Biotechnologyfinance.yahoo.com - May 30 at 11:25 PMNeedham Reiterates Rocket Pharmaceuticals (RCKT) Buy Recommendationmsn.com - April 20 at 7:49 AMChardan Capital Maintains Immuneering Corp (IMRX) Buy Recommendationmsn.com - April 20 at 7:49 AMEF Hutton Reiterates Adaptimmune Therapeutics (ADAP) Buy Recommendationmsn.com - April 11 at 7:41 PMWedbush Initiates Coverage of Janux Therapeutics (JANX) with Outperform Recommendationmsn.com - April 7 at 3:17 AMCitigroup Maintains Applied Therapeutics (APLT) Buy Recommendationmsn.com - April 5 at 6:08 PMToth Financial Advisory Corp Has $979,000 Position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)marketbeat.com - April 2 at 6:42 AMProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.0198msn.com - December 23 at 9:09 AMBiotech ETFs rally in Q4 fueled by 70%+ surge in Modernamsn.com - December 22 at 5:47 PMProShares launches an ETF meant to capitalize on the growing demand for batteriesseekingalpha.com - December 1 at 5:23 PMHow to Invest in Biotech in 2022nasdaq.com - December 16 at 7:28 AMatai Life Sciences Has Been Selected for Addition to the NASDAQ Biotechnology Indexfinance.yahoo.com - December 13 at 8:15 AMBIBseekingalpha.com - October 23 at 12:26 AMCould Biotech ETFs Get Another Boost From JNJ News?nasdaq.com - August 27 at 2:47 AMTap the Red Hot Biotech Sector With These 2 Leveraged ETFsnasdaq.com - August 26 at 4:45 PMPfizer-BioNTech COVID-19 Vaccine Garners Full FDA Approvalnasdaq.com - August 24 at 6:23 PMBiotech ETFs Are Already Benefitting from Pfizer Vaccine’s Full Approvalnasdaq.com - August 23 at 3:49 PM Get ProShares Ultra Nasdaq Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for BIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now BIB Media Mentions By Week BIB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIB News Sentiment▼1.440.95▲Average News Sentiment BIB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIB Articles This Week▼40▲BIB Articles Average Week Get ProShares Ultra Nasdaq Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for BIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Principal Healthcare Innovators ETF News Invesco Nasdaq Biotechnology ETF News Invesco S&P SmallCap Health Care ETF News VanEck Biotech ETF News VanEck Pharmaceutical ETF News iShares Biotechnology ETF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIB) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.